Why You Should Have Life Science Real Estate in Your Portfolio
The need for life science properties is growing exponentially in the United States -- and not just for developing COVID-19 vaccines and treatments. Innovation in the healthcare industry has never been more active, and the need for state-of-the art properties to conduct research and development is increasing.
In this Dec. 1 Fool Live video clip, two experts from The Motley Fool's Millionacres real estate subsidiary, editor Deidre Woollard and Certified Financial Planner Matt Frankel discuss what investors should know about the life science real estate business.
Source Fool.com